USPTO Officially Withdraws Terminal Disclaimer ProposalUSPTO has withdrawn a proposed rule that could have imposed new limitations on terminal disclaimers, ensuring a predictable patent environment for the biopharmaceutical sector.
Free Post: Not Yet in Effect: Clarifying Misconceptions About the USPTO's Proposed Terminal Disclaimer RuleThe proposed USPTO terminal disclaimer rules are not yet in effect and will impact future practices when finalized.New requirements for terminal disclaimers may complicate patent applicants' decisions regarding enforceability.
USPTO Officially Withdraws Terminal Disclaimer ProposalUSPTO has withdrawn a proposed rule that could have imposed new limitations on terminal disclaimers, ensuring a predictable patent environment for the biopharmaceutical sector.
Free Post: Not Yet in Effect: Clarifying Misconceptions About the USPTO's Proposed Terminal Disclaimer RuleThe proposed USPTO terminal disclaimer rules are not yet in effect and will impact future practices when finalized.New requirements for terminal disclaimers may complicate patent applicants' decisions regarding enforceability.
Changes to AI Patent Practice in View of the USPTO's Recent ActionsApplicants cautious of filing terminal disclaimer under Proposed TD Rule may make all claims vulnerable; USPTO's actions drastically impact AI patenting.